|
NSCLC is a disease in which cancer cells form in the tissues of the lung. These cells multiply to form tumors in the lung and can spread to other parts of the body. NSCLC is said to be “advanced” when it has spread to the lymph nodes, the other lung, or other areas of the body.
Novartis Oncology is currently conducting clinical trials to learn whether the study drug ASA404, when given with other standard chemotherapy treatments, can improve survival in patients with advanced NSCLC. Your physical state, changes in your cancer, and laboratory findings observed during the trial will determine if ASA404 is safe and effective in the treatment of advanced NSCLC.
|
For U.S. residents only.
Non-U.S. residents
